163 related articles for article (PubMed ID: 2207106)
1. Role of membrane lipids in the interaction of daunomycin with plasma membranes from tumor cells: implications in drug-resistance phenomena.
Escriba PV; Ferrer-Montiel AV; Ferragut JA; Gonzalez-Ros JM
Biochemistry; 1990 Aug; 29(31):7275-82. PubMed ID: 2207106
[TBL] [Abstract][Full Text] [Related]
2. Different distribution of daunomycin in plasma membranes from drug-sensitive and drug-resistant P388 leukemia cells.
Ferrer-Montiel AV; Gonzalez-Ros JM; Ferragut JA
Biochim Biophys Acta; 1992 Feb; 1104(1):111-6. PubMed ID: 1550837
[TBL] [Abstract][Full Text] [Related]
3. Rapid kinetics of the interaction between daunomycin and drug-sensitive or drug-resistant P388 leukemia cells.
Soto F; Canaves JM; Gonzalez-Ros JM; Ferragut JA
FEBS Lett; 1992 Apr; 301(1):119-23. PubMed ID: 1451781
[TBL] [Abstract][Full Text] [Related]
4. Equilibrium, kinetic and photoaffinity labeling studies of daunomycin binding to P-glycoprotein-containing membranes of multidrug-resistant Chinese hamster ovary cells.
Busche R; Tümmler B; Cano-Gauci DF; Riordan JR
Eur J Biochem; 1989 Jul; 183(1):189-97. PubMed ID: 2568928
[TBL] [Abstract][Full Text] [Related]
5. Preparation and interaction of a low-density lipoprotein:daunomycin complex with P388 leukemic cells.
Iwanik MJ; Shaw KV; Ledwith BJ; Yanovich S; Shaw JM
Cancer Res; 1984 Mar; 44(3):1206-15. PubMed ID: 6692404
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructural alterations in plasma membranes from drug-resistant P388 murine leukemia cells.
García-Segura LM; Ferragut JA; Ferrer-Montiel AV; Escriba PV; Gonzalez-Ros JM
Biochim Biophys Acta; 1990 Nov; 1029(1):191-5. PubMed ID: 1977472
[TBL] [Abstract][Full Text] [Related]
7. Binding of daunomycin to acidic phospholipids.
Schreier H
J Parenter Sci Technol; 1989; 43(5):213-9. PubMed ID: 2809929
[TBL] [Abstract][Full Text] [Related]
8. Differences in daunomycin retention in sensitive and resistant P388 leukemic cells as determined by digitized video fluorescence microscopy.
Yanovich S; Taub RN
Cancer Res; 1983 Sep; 43(9):4167-71. PubMed ID: 6871858
[TBL] [Abstract][Full Text] [Related]
9. Association of daunomycin to membrane domains studied by fluorescence resonance energy transfer.
Ferrer-Montiel AV; Gonzalez-Ros JM; Ferragut JA
Biochim Biophys Acta; 1988 Jan; 937(2):379-86. PubMed ID: 3337808
[TBL] [Abstract][Full Text] [Related]
10. Selectivity of the anthracyclines for negatively charged model membranes: role of the amino group.
Burke TG; Sartorelli AC; Tritton TR
Cancer Chemother Pharmacol; 1988; 21(4):274-80. PubMed ID: 3370735
[TBL] [Abstract][Full Text] [Related]
11. Ca(2+)-dependent binding of endonexin (annexin IV) to membranes: analysis of the effects of membrane lipid composition and development of a predictive model for the binding interaction.
Junker M; Creutz CE
Biochemistry; 1994 Aug; 33(30):8930-40. PubMed ID: 8043580
[TBL] [Abstract][Full Text] [Related]
12. Differences in lipid composition of doxorubicin-sensitive and -resistant P388 cells.
Ramu A; Glaubiger D; Weintraub H
Cancer Treat Rep; 1984 Apr; 68(4):637-41. PubMed ID: 6713419
[TBL] [Abstract][Full Text] [Related]
13. Verapamil reverses the ultrastructural alterations in the plasma membrane induced by drug resistance.
García-Segura LM; Soto F; Planells-Cases R; Gonzalez-Ros JM; Ferragut JA
FEBS Lett; 1992 Dec; 314(3):404-8. PubMed ID: 1468576
[TBL] [Abstract][Full Text] [Related]
14. The relationship between plasma membrane lipid composition and physical-chemical properties. III. Detailed physical and biochemical analysis of fatty acid-substituted EL4 plasma membranes.
Poon R; Clark WH
Biochim Biophys Acta; 1982 Jul; 689(2):230-40. PubMed ID: 6288097
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of uptake and cytotoxicity of a low-density lipoprotein-daunomycin complex in P388 leukemic cells.
Yanovich S; Preston L; Shaw JM
Cancer Res; 1984 Aug; 44(8):3377-82. PubMed ID: 6744272
[TBL] [Abstract][Full Text] [Related]
16. Interaction of anthracyclines with plasma membranes from tumour cells: implications on drug resistance.
González-Ros JM; Ferrer-Montiel AV; Soto F; Escriba PV; Ferragut JA
Biochem Soc Trans; 1989 Dec; 17(6):964-5. PubMed ID: 2697620
[No Abstract] [Full Text] [Related]
17. [Phospholipid and cholesterol levels in the tumor cell plasma membranes with different sensitivity to doxorubicin].
Chekhun VF; Tryndiak VP; Todor IM; Mykhaĭlenko VM; Kondrychyn IH; Dovbeshko HI; Repnyts'ka OP; Kulyk HI
Ukr Biokhim Zh (1999); 2003; 75(4):120-5. PubMed ID: 14681985
[TBL] [Abstract][Full Text] [Related]
18. Phospholipid composition modulates the Na+-Ca2+ exchange activity of cardiac sarcolemma in reconstituted vesicles.
Vemuri R; Philipson KD
Biochim Biophys Acta; 1988 Jan; 937(2):258-68. PubMed ID: 3276350
[TBL] [Abstract][Full Text] [Related]
19. Verapamil prevents the effects of daunomycin on the thermotropic phase transition of model lipid bilayers.
Canaves JM; Ferragut JA; Gonzalez-Ros JM
Biochem J; 1991 Oct; 279 ( Pt 2)(Pt 2):413-8. PubMed ID: 1953639
[TBL] [Abstract][Full Text] [Related]
20. Role of anionic phospholipids in the interaction of doxorubicin and plasma membrane vesicles: drug binding and structural consequences in bacterial systems.
de Wolf FA; Staffhorst RW; Smits HP; Onwezen MF; de Kruijff B
Biochemistry; 1993 Jul; 32(26):6688-95. PubMed ID: 8329395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
